Hidden Cove Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$635K Buy
549
+15
+3% +$17.7K 0.34% 51
2026
Q2
$640K Buy
534
+125
+31% +$128K 0.35% 53
2026
Q1
$376K Buy
409
+15
+4% +$15.2K 0.24% 63
2025
Q4
$423K Sell
394
-12
-3% -$11.5K 0.27% 52
2025
Q3
$310K Buy
406
+72
+22% +$53.6K 0.2% 61
2025
Q2
$260K Sell
334
-11
-3% -$8.55K 0.19% 61
2025
Q1
$285K Buy
345
+69
+25% +$57.4K 0.23% 48
2024
Q4
$213K Buy
+276
New +$229K 0.17% 58

Other funds holding LLY

Hidden Cove Wealth Management's LLY Position: Q3 2026 in Review

Hidden Cove Wealth Management increased its Eli Lilly (LLY) stake by 2.8% in Q3 2026, buying an estimated $17.7K and bringing the position to 549 shares worth $635K. The position accounts for 0.34% of the portfolio, ranked #51.

Hidden Cove Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $640K in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Hidden Cove Wealth Management held 549 shares of Eli Lilly worth $635K as of Q3 2026.
  • Hidden Cove Wealth Management bought 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
  • Eli Lilly made up 0.34% of Hidden Cove Wealth Management's portfolio in Q3 2026, its #51 holding.
  • Hidden Cove Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Hidden Cove Wealth Management's Eli Lilly position peaked at $640K in Q2 2026.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Hidden Cove Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.